| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8773841 | Kidney International Reports | 2018 | 7 Pages |
Abstract
This study advances efforts to validate CD80 as a therapeutic target for treatment-resistant nephrotic syndrome, and implements a precision medicine-based approach to this serious kidney condition in which the selection of a therapeutic agent is guided by the underlying disease mechanism operating in individual patients.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Howard Trachtman, Debbie S. Gipson, Michael Somers, Cathie Spino, Sharon Adler, Lawrence Holzman, Jeffrey B. Kopp, John Sedor, Sandra Overfield, Ayanbola Elegbe, Michael Maldonado, Anna Greka,